Literature DB >> 710022

Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations.

S N Anavekar, R H Saunders, W M Wardell, I Shoulson, F G Emmings, C E Cook, A J Gringeri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 710022     DOI： 10.1002/cpt1978246629

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.

Authors:  J J MacKichan; P K Duffner; M E Cohen
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

3.  Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.

Authors:  C Knott; A Hamshaw-Thomas; F Reynolds
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-02

4.  Reproducibility of saliva and plasma theophylline levels following single dose administration of two sustained release preparations.

Authors:  A H Jackson; C Edwards; A S Cope; R A Stockley; R Purkiss
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  Factors determining the passage of drugs from blood into saliva.

Authors:  K W Stephen; J McCrossan; D Mackenzie; C B Macfarlane; C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease.

Authors:  M L Friis; T Johnsen; N E Larsen; E F Hvidberg; H Pakkenberg
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.